Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Capecitabine and Oxaliplatin After Resection of Colorectal Liver Metastases
NCT00156975Phase 3Unknown
- Sponsor
- Arbeitsgruppe Lebermetastasen und Tumoren
- Start
- Nov 2004
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, oxaliplatin in colorectal cancer (CRC), sponsored by Arbeitsgruppe Lebermetastasen und Tumoren. Status: unknown.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00156975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156975.